Report Detail

Pharma & Healthcare Global Self-amplifying RNA (saRNA) Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4586846
  • |
  • 09 April, 2024
  • |
  • Global
  • |
  • 119 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Self-amplifying RNA (saRNA) Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
saRNA is an RNA that shares many structural similarities with mRNA: it is a linear, single-stranded RNA molecule synthesized from a 5' cap, a 3' poly(A) tail, and 5' and 3' UTRs. The main difference is that saRNA is a larger molecule because it encodes four additional proteins in addition to the vaccine antigen or gene of interest. These four additional proteins are nonstructural proteins, usually derived from alphaviruses, encoding replicase enzymes. This replicase is able to amplify the original RNA strand upon delivery to cells, resulting in higher amounts of protein expression with minimal RNA dosage required.
The Global Info Research report includes an overview of the development of the Self-amplifying RNA (saRNA) Drugs industry chain, the market status of Infectious Disease (Preventive Medicine, Medicine), Cancer (Preventive Medicine, Medicine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Self-amplifying RNA (saRNA) Drugs.
Regionally, the report analyzes the Self-amplifying RNA (saRNA) Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Self-amplifying RNA (saRNA) Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Self-amplifying RNA (saRNA) Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Self-amplifying RNA (saRNA) Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Preventive Medicine, Medicine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Self-amplifying RNA (saRNA) Drugs market.
Regional Analysis: The report involves examining the Self-amplifying RNA (saRNA) Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Self-amplifying RNA (saRNA) Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Self-amplifying RNA (saRNA) Drugs:
Company Analysis: Report covers individual Self-amplifying RNA (saRNA) Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Self-amplifying RNA (saRNA) Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Infectious Disease, Cancer).
Technology Analysis: Report covers specific technologies relevant to Self-amplifying RNA (saRNA) Drugs. It assesses the current state, advancements, and potential future developments in Self-amplifying RNA (saRNA) Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Self-amplifying RNA (saRNA) Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Self-amplifying RNA (saRNA) Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Preventive Medicine
Medicine
Market segment by Application
Infectious Disease
Cancer
Others
Major players covered
Chimeron Bio
Ziphius Vaccines
Aldevron
VaxEquity
Precision Nanosystems
Replicate Bioscience
Elixirgen Therapeutics
Immorna
CSL
Arcturus Therapeutics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Self-amplifying RNA (saRNA) Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Self-amplifying RNA (saRNA) Drugs, with price, sales, revenue and global market share of Self-amplifying RNA (saRNA) Drugs from 2019 to 2024.
Chapter 3, the Self-amplifying RNA (saRNA) Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Self-amplifying RNA (saRNA) Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Self-amplifying RNA (saRNA) Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Self-amplifying RNA (saRNA) Drugs.
Chapter 14 and 15, to describe Self-amplifying RNA (saRNA) Drugs sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Self-amplifying RNA (saRNA) Drugs
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Self-amplifying RNA (saRNA) Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Preventive Medicine
    • 1.3.3 Medicine
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Self-amplifying RNA (saRNA) Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Infectious Disease
    • 1.4.3 Cancer
    • 1.4.4 Others
  • 1.5 Global Self-amplifying RNA (saRNA) Drugs Market Size & Forecast
    • 1.5.1 Global Self-amplifying RNA (saRNA) Drugs Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Self-amplifying RNA (saRNA) Drugs Sales Quantity (2019-2030)
    • 1.5.3 Global Self-amplifying RNA (saRNA) Drugs Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Chimeron Bio
    • 2.1.1 Chimeron Bio Details
    • 2.1.2 Chimeron Bio Major Business
    • 2.1.3 Chimeron Bio Self-amplifying RNA (saRNA) Drugs Product and Services
    • 2.1.4 Chimeron Bio Self-amplifying RNA (saRNA) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Chimeron Bio Recent Developments/Updates
  • 2.2 Ziphius Vaccines
    • 2.2.1 Ziphius Vaccines Details
    • 2.2.2 Ziphius Vaccines Major Business
    • 2.2.3 Ziphius Vaccines Self-amplifying RNA (saRNA) Drugs Product and Services
    • 2.2.4 Ziphius Vaccines Self-amplifying RNA (saRNA) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Ziphius Vaccines Recent Developments/Updates
  • 2.3 Aldevron
    • 2.3.1 Aldevron Details
    • 2.3.2 Aldevron Major Business
    • 2.3.3 Aldevron Self-amplifying RNA (saRNA) Drugs Product and Services
    • 2.3.4 Aldevron Self-amplifying RNA (saRNA) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Aldevron Recent Developments/Updates
  • 2.4 VaxEquity
    • 2.4.1 VaxEquity Details
    • 2.4.2 VaxEquity Major Business
    • 2.4.3 VaxEquity Self-amplifying RNA (saRNA) Drugs Product and Services
    • 2.4.4 VaxEquity Self-amplifying RNA (saRNA) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 VaxEquity Recent Developments/Updates
  • 2.5 Precision Nanosystems
    • 2.5.1 Precision Nanosystems Details
    • 2.5.2 Precision Nanosystems Major Business
    • 2.5.3 Precision Nanosystems Self-amplifying RNA (saRNA) Drugs Product and Services
    • 2.5.4 Precision Nanosystems Self-amplifying RNA (saRNA) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Precision Nanosystems Recent Developments/Updates
  • 2.6 Replicate Bioscience
    • 2.6.1 Replicate Bioscience Details
    • 2.6.2 Replicate Bioscience Major Business
    • 2.6.3 Replicate Bioscience Self-amplifying RNA (saRNA) Drugs Product and Services
    • 2.6.4 Replicate Bioscience Self-amplifying RNA (saRNA) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Replicate Bioscience Recent Developments/Updates
  • 2.7 Elixirgen Therapeutics
    • 2.7.1 Elixirgen Therapeutics Details
    • 2.7.2 Elixirgen Therapeutics Major Business
    • 2.7.3 Elixirgen Therapeutics Self-amplifying RNA (saRNA) Drugs Product and Services
    • 2.7.4 Elixirgen Therapeutics Self-amplifying RNA (saRNA) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Elixirgen Therapeutics Recent Developments/Updates
  • 2.8 Immorna
    • 2.8.1 Immorna Details
    • 2.8.2 Immorna Major Business
    • 2.8.3 Immorna Self-amplifying RNA (saRNA) Drugs Product and Services
    • 2.8.4 Immorna Self-amplifying RNA (saRNA) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Immorna Recent Developments/Updates
  • 2.9 CSL
    • 2.9.1 CSL Details
    • 2.9.2 CSL Major Business
    • 2.9.3 CSL Self-amplifying RNA (saRNA) Drugs Product and Services
    • 2.9.4 CSL Self-amplifying RNA (saRNA) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 CSL Recent Developments/Updates
  • 2.10 Arcturus Therapeutics
    • 2.10.1 Arcturus Therapeutics Details
    • 2.10.2 Arcturus Therapeutics Major Business
    • 2.10.3 Arcturus Therapeutics Self-amplifying RNA (saRNA) Drugs Product and Services
    • 2.10.4 Arcturus Therapeutics Self-amplifying RNA (saRNA) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Arcturus Therapeutics Recent Developments/Updates

3 Competitive Environment: Self-amplifying RNA (saRNA) Drugs by Manufacturer

  • 3.1 Global Self-amplifying RNA (saRNA) Drugs Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Self-amplifying RNA (saRNA) Drugs Revenue by Manufacturer (2019-2024)
  • 3.3 Global Self-amplifying RNA (saRNA) Drugs Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Self-amplifying RNA (saRNA) Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Self-amplifying RNA (saRNA) Drugs Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Self-amplifying RNA (saRNA) Drugs Manufacturer Market Share in 2023
  • 3.5 Self-amplifying RNA (saRNA) Drugs Market: Overall Company Footprint Analysis
    • 3.5.1 Self-amplifying RNA (saRNA) Drugs Market: Region Footprint
    • 3.5.2 Self-amplifying RNA (saRNA) Drugs Market: Company Product Type Footprint
    • 3.5.3 Self-amplifying RNA (saRNA) Drugs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Self-amplifying RNA (saRNA) Drugs Market Size by Region
    • 4.1.1 Global Self-amplifying RNA (saRNA) Drugs Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Self-amplifying RNA (saRNA) Drugs Consumption Value by Region (2019-2030)
    • 4.1.3 Global Self-amplifying RNA (saRNA) Drugs Average Price by Region (2019-2030)
  • 4.2 North America Self-amplifying RNA (saRNA) Drugs Consumption Value (2019-2030)
  • 4.3 Europe Self-amplifying RNA (saRNA) Drugs Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Self-amplifying RNA (saRNA) Drugs Consumption Value (2019-2030)
  • 4.5 South America Self-amplifying RNA (saRNA) Drugs Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Self-amplifying RNA (saRNA) Drugs Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Self-amplifying RNA (saRNA) Drugs Sales Quantity by Type (2019-2030)
  • 5.2 Global Self-amplifying RNA (saRNA) Drugs Consumption Value by Type (2019-2030)
  • 5.3 Global Self-amplifying RNA (saRNA) Drugs Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Self-amplifying RNA (saRNA) Drugs Sales Quantity by Application (2019-2030)
  • 6.2 Global Self-amplifying RNA (saRNA) Drugs Consumption Value by Application (2019-2030)
  • 6.3 Global Self-amplifying RNA (saRNA) Drugs Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Self-amplifying RNA (saRNA) Drugs Sales Quantity by Type (2019-2030)
  • 7.2 North America Self-amplifying RNA (saRNA) Drugs Sales Quantity by Application (2019-2030)
  • 7.3 North America Self-amplifying RNA (saRNA) Drugs Market Size by Country
    • 7.3.1 North America Self-amplifying RNA (saRNA) Drugs Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Self-amplifying RNA (saRNA) Drugs Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Self-amplifying RNA (saRNA) Drugs Sales Quantity by Type (2019-2030)
  • 8.2 Europe Self-amplifying RNA (saRNA) Drugs Sales Quantity by Application (2019-2030)
  • 8.3 Europe Self-amplifying RNA (saRNA) Drugs Market Size by Country
    • 8.3.1 Europe Self-amplifying RNA (saRNA) Drugs Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Self-amplifying RNA (saRNA) Drugs Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Self-amplifying RNA (saRNA) Drugs Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Self-amplifying RNA (saRNA) Drugs Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Self-amplifying RNA (saRNA) Drugs Market Size by Region
    • 9.3.1 Asia-Pacific Self-amplifying RNA (saRNA) Drugs Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Self-amplifying RNA (saRNA) Drugs Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Self-amplifying RNA (saRNA) Drugs Sales Quantity by Type (2019-2030)
  • 10.2 South America Self-amplifying RNA (saRNA) Drugs Sales Quantity by Application (2019-2030)
  • 10.3 South America Self-amplifying RNA (saRNA) Drugs Market Size by Country
    • 10.3.1 South America Self-amplifying RNA (saRNA) Drugs Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Self-amplifying RNA (saRNA) Drugs Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Self-amplifying RNA (saRNA) Drugs Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Self-amplifying RNA (saRNA) Drugs Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Self-amplifying RNA (saRNA) Drugs Market Size by Country
    • 11.3.1 Middle East & Africa Self-amplifying RNA (saRNA) Drugs Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Self-amplifying RNA (saRNA) Drugs Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Self-amplifying RNA (saRNA) Drugs Market Drivers
  • 12.2 Self-amplifying RNA (saRNA) Drugs Market Restraints
  • 12.3 Self-amplifying RNA (saRNA) Drugs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Self-amplifying RNA (saRNA) Drugs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Self-amplifying RNA (saRNA) Drugs
  • 13.3 Self-amplifying RNA (saRNA) Drugs Production Process
  • 13.4 Self-amplifying RNA (saRNA) Drugs Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Self-amplifying RNA (saRNA) Drugs Typical Distributors
  • 14.3 Self-amplifying RNA (saRNA) Drugs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Self-amplifying RNA (saRNA) Drugs. Industry analysis & Market Report on Self-amplifying RNA (saRNA) Drugs is a syndicated market report, published as Global Self-amplifying RNA (saRNA) Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Self-amplifying RNA (saRNA) Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,731.80
    4,097.70
    5,463.60
    3,208.56
    4,812.84
    6,417.12
    546,325.20
    819,487.80
    1,092,650.40
    289,222.80
    433,834.20
    578,445.60
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report